The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways

被引:39
作者
Alessio, N. [2 ,3 ]
Squillaro, T. [2 ,4 ]
Cipollaro, M. [1 ]
Bagella, L. [2 ,3 ]
Giordano, A. [2 ,5 ,6 ]
Galderisi, U. [1 ,2 ]
机构
[1] Univ Naples 2, Biotechnol & Mol Biol Sect, Dept Expt Med, I-80138 Naples, Italy
[2] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA
[3] Univ Sassari, Dept Biomed Sci, Div Biochem & Biophys, I-07100 Sassari, Italy
[4] Univ Siena, I-53100 Siena, Italy
[5] Univ Siena, Human Pathol & Oncol Dept, I-53100 Siena, Italy
[6] Human Hlth Fdn, Spoleto, Italy
关键词
stem cells; senescence; apoptosis; p53; retinoblastoma; chromatin; RETINOBLASTOMA PROTEIN; STROMAL CELLS; DNA-REPAIR; TUMOR-SUPPRESSOR; GROWTH ARREST; P53; DIFFERENTIATION; APOPTOSIS; BINDING; GENE;
D O I
10.1038/onc.2010.285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We focused our attention on brahma-related gene 1 (BRG1), the ATPase subunit of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex, and analyzed its role in mesenchymal stem cell (MSC) biology. We hypothesized that deviation from the correct concentration of these proteins, which act at the highest level of gene regulation, may be deleterious for cells. We wanted to know what would happen if a cell had to cope with altered regulation of gene expression, either by upregulation or downregulation of BRG1. We assumed that cells would try to restore homeostasis or, alternatively, that the event could trigger senescence/apoptosis phenomena. To this end, in MSCs, we silenced BRG1gene. Knockdown of BRG1 expression induced a significant increase in senescent cells and decrease in apoptotic cells. It is interesting that BRG1 downregulation also induced an increase in heterochromatin. At the molecular level, these phenomena were associated with activation of retinoblastoma-like protein 2 (RB2)/P130-and P53-related pathways. Senescence was accompanied by reduced expression of some stemness-related genes. This is consistent with our previous research, which showed that BRG1 upregulation by ectopic expression also induced senescence processes. Together, these data suggest that BRG1 belongs to a class of genes whose expression is tightly regulated; hence, subtle alterations in BRG1 activity seem to negatively affect mechanisms regulating chromatin status and, in turn, impair cellular physiology. Oncogene (2010) 29, 5452-5463; doi:10.1038/onc.2010.285; published online 9 August 2010
引用
收藏
页码:5452 / 5463
页数:12
相关论文
共 68 条
  • [1] Alves H, 2009, J CELL MOL MED
  • [2] Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249
  • [3] Post-translational modification of p53 in tumorigenesis
    Bode, AM
    Dong, ZG
    [J]. NATURE REVIEWS CANCER, 2004, 4 (10) : 793 - 805
  • [4] A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes
    Bultman, S
    Gebuhr, T
    Yee, D
    La Mantia, C
    Nicholson, J
    Gilliam, A
    Randazzo, F
    Metzger, D
    Chambon, P
    Crabtree, G
    Magnuson, T
    [J]. MOLECULAR CELL, 2000, 6 (06) : 1287 - 1295
  • [5] Cellular senescence: when bad things happen to good cells
    Campisi, Judith
    di Fagagna, Fabrizio d'Adda
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) : 729 - 740
  • [6] Cellular senescence in cancer and aging
    Collado, Manuel
    Blasco, Maria A.
    Serrano, Manuel
    [J]. CELL, 2007, 130 (02) : 223 - 233
  • [7] Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers
    de la Serna, Ivana L.
    Ohkawa, Yasuyuki
    Imbalzano, Anthony N.
    [J]. NATURE REVIEWS GENETICS, 2006, 7 (06) : 461 - 473
  • [8] Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
    Debacq-Chainiaux, Florence
    Erusalimsky, Jorge D.
    Campisi, Judith
    Toussaint, Olivier
    [J]. NATURE PROTOCOLS, 2009, 4 (12) : 1798 - 1806
  • [9] Development of a rapid, small-scale DNA repair assay for use on clinical samples
    Diggle, CP
    Bentley, J
    Kiltie, AE
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (15) : e83
  • [10] Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    Dominici, M.
    Le Blanc, K.
    Mueller, I.
    Slaper-Cortenbach, I.
    Marini, F. C.
    Krause, D. S.
    Deans, R. J.
    Keating, A.
    Prockop, D. J.
    Horwitz, E. M.
    [J]. CYTOTHERAPY, 2006, 8 (04) : 315 - 317